<html>
<head>PUBMED IDs for RPRM</head>
<body bgcolor='#C5F0F2'><h1>RPRM</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18310272/'>The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310270/'>&quot;SCA16&quot; is really SCA15.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310267/'>Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310265/'>A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310264/'>Heterogeneity in the processing defect of SLC26A4 mutants.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18310263/'>Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19218281/'>Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.</a> July 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19917725/'>Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM.</a> January 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20154727/'>Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.</a> May 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20178103/'>Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer.</a> November 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21810943/'>Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.</a> November 11  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22562171/'>Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.</a> September 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24390737/'>Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.</a> June 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25629980/'>tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.</a> September 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25954972/'>Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.</a> April 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26616534/'>Transcriptome analysis of human OXR1 depleted cells reveals its role in regulating the p53 signaling pathway.</a> October 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27992600/'>Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer.</a> December 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28562620/'>Reprimo tissue-specific expression pattern is conserved between zebrafish and human.</a> June 1  2017<br></body></html>
